je.st
news
Tag: therapeutics
04.01.16 -- Overcome Formulation Challenges Of Protein-Based Therapeutics
2016-03-31 02:38:40| drugdiscoveryonline Home Page
04/01/16 Drug Discovery Online Newsletter
Tags: challenges
overcome
formulation
therapeutics
Allied-Bristol Life Sciences Launches ieCa Therapeutics From NYU School Of Medicine To Develop Novel Cancer Therapeutics Targeting The Wnt Pathway
2016-03-30 07:03:23| drugdiscoveryonline Home Page
Allied-Bristol Life Sciences, LLC (ABLS), a biopharmaceutical enterprise jointly owned between Allied Minds and Bristol-Myers Squibb Company, announced that it has launched a new subsidiary, iβeCa Therapeutics, to license proprietary compounds from NYU School of Medicine that target the Wnt signalling pathway
Reset Therapeutics, Inc. Establishes Research Collaboration With Alkermes For Discovery And Development Of Novel Orexin Modulators
2016-03-30 06:05:57| drugdiscoveryonline Home Page
Reset Therapeutics, Inc., announced recently a collaboration with an affiliate of Alkermes plc for the discovery, development and commercialization of novel orexin receptor modulators from Reset’s drug discovery platform
Tags: research
development
novel
collaboration
Bristol-Myers Squibb To Acquire Padlock Therapeutics, Inc.
2016-03-30 03:53:43| drugdiscoveryonline Home Page
Bristol-Myers Squibb Company and Padlock Therapeutics, Inc. announced recently that the companies have signed a definitive agreement under which Bristol-Myers Squibb will acquire all of the outstanding capital stock of Padlock, a private, Cambridge, Massachusetts-based biotechnology company dedicated to creating new medicines to treat destructive autoimmune diseases
Tags: acquire
therapeutics
squibb
padlock
Insys Therapeutics: Is The Price Downfall Justified ?
2016-03-29 20:22:32| Biotech - Topix.net
Insys Therapeutics , headquartered in Chandler, Arizona develops cancer support drugs based on opioids. Since the authorization of their first product in 2012, the company has been acknowledging an important increase of 1,335% of their revenue between 2012 and 2014.
Tags: price
justified
therapeutics
downfall
Sites : [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] next »